193 research outputs found
Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1
Although gemcitabine is the most commonly used drug for treating pancreatic cancers, acquired gemcitabine resistance in a substantial number of patients appears to hinder its effectiveness in successful treatment of this dreadful disease. To understand acquired gemcitabine resistance, we generated a gemcitabine-resistant pancreatic cancer cell line using stepwise selection and found that, in addition to the known mechanisms of upregulated expression of ribonucleotide reductase, 14-3-3σ expression is dramatically upregulated, and that 14-3-3σ overexpression contributes to the acquired resistance to gemcitabine and cross-resistance to cytarabine. We also found that the increased 14-3-3σ expression in the gemcitabine-resistant cells is due to demethylation of the 14-3-3σ gene during gemcitabine selection, which could be partially reversed with removal of the gemcitabine selection pressure. Most importantly, the reversible methylation/demethylation of the 14-3-3σ gene appears to be carried out by DNA methyltransferase 1 under regulation by Uhrf1. These findings suggest that the epigenetic regulation of gene expression may play an important role in gemcitabine resistance, and that epigenetic modification is reversible in response to gemcitabine treatment
14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression
Gemcitabine is an important anticancer therapeutics approved for treatment of several human cancers including locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). Its clinical effectiveness, however, is hindered by existence of intrinsic and development of acquired resistances. Previously, it was found that 14-3-3σ expression associates with poor clinical outcome of PDAC patients. It was also found that 14-3-3σ expression is up-regulated in gemcitabine resistant PDAC cells and contributes to the acquired gemcitabine resistance. In this study, we investigated the molecular mechanism of 14-3-3σ function in gemcitabine resistance and found that 14-3-3σ up-regulates YAP1 expression and then binds to YAP1 to inhibit gemcitabine-induced caspase 8 activation and apoptosis. 14-3-3σ association with YAP1 up-regulates the expression of ribonucleotide reductase M1 and M2, which may mediate 14-3-3σ/YAP1 function in the acquired gemcitabine resistance. These findings suggest a possible role of YAP1 signaling in gemcitabine resistance
EIF3i Promotes Colon Oncogenesis by Regulating COX-2 Protein Synthesis and β-Catenin Activation
Translational control of gene expression has recently been recognized as an important mechanism controlling cell proliferation and oncogenesis and it mainly occurs in the initiation step of protein synthesis that involves multiple eukaryotic initiation factors (eIFs). Many eIFs have been found to have aberrant expression in human tumors and the aberrant expression may contribute to oncogenesis. However, how these previously considered house-keeping proteins are potentially oncogenic remains elusive. In this study, we investigated the expression of eIF3i in human colon cancers, tested its contribution to colon oncogenesis, and determined the mechanism of eIF3i action in colon oncogenesis. We found that eIF3i expression was up-regulated in both human colon adenocarcinoma and adenoma polyps as well as in model inducible colon tumorigenic cell lines. Over-expression of ectopic eIF3i in intestinal epithelial cells causes oncogenesis by directly up-regulating synthesis of COX-2 protein and activates the β-catenin/TCF4 signaling pathway that mediates the oncogenic function of eIF3i. Together, we conclude that eIF3i is a proto-oncogene that drives colon oncogenesis by translationally up-regulating COX-2 and activating β-catenin signaling pathway. These findings imply that protooncogenic eIFs likely exert their tumorigenic function by regulating/altering the synthesis level of down-stream tumor suppressor or oncogenes
Effective targeting of the survivin dimerization interface with small molecule inhibitors
Many oncoproteins are considered undruggable because they lack enzymatic activities. In this study, we present a small-molecule–based anticancer agent that acts by inhibiting dimerization of the oncoprotein survivin, thereby promoting its degradation along with spontaneous apoptosis in cancer cells. Through a combination of computational analysis of the dimerization interface and in silico screening, we identified one compound that induced proteasome-dependent survivin degradation. Analysis of a set of structural analogues led us to identify a lead compound (LQZ-7F), which was effective in blocking the survival of multiple cancer cell lines in a low micromolar concentration range. LQZ-7F induced proteasome-dependent survivin degradation, mitotic arrest, and apoptosis, and it blocked the growth of human tumors in mouse xenograft assays. In addition to providing preclinical proof of concept for a survivin-targeting anticancer agent, our work offers novel in silico screening strategies to therapeutically target homodimeric oncogenic proteins considered undruggable
An Innovative Approach for Gob-Side Entry Retaining With Thick and Hard Roof: A Case Study
An innovative roadway layout in a Chinese colliery based on gob-side entry retaining (GER) with thick and hard roof (THR) was introduced. Suspended roof is left with a large area in GER with THR, which leads to large area roof weighting (LARW). LARW for GER with THR and mechanism of shallow-hole blasting to force roof caving in GER were expounded. Key parameters of shallow-hole blasting to force roof caving are proposed. LS-DYNA3D was used to validate the rationality of those key parameters, and UDEC was used to discuss and validate shallow-hole blasting to force roof-caving effect by contrast to the model without blasting and the model with shallow-hole blasting. Moreover, shallow-hole blasting technology to force roof caving for GER with THR was carried out in the Chinese colliery as a case study. Field test indicates that shallow-hole blasting technology effectively controls ground deformation of GER with THR and prevents LARW
A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion
Signal transducer and activator of
transcription 3 (STAT3) plays
important roles in multiple aspects of cancer aggressiveness including
migration, invasion, survival, self-renewal, angiogenesis, and tumor
cell immune evasion by regulating the expression of multiple downstream
target genes. STAT3 is constitutively activated in many malignant
tumors and its activation is associated with high histological grade
and advanced cancer stages. Thus, inhibiting STAT3 promises an attracting
strategy for treatment of advanced and metastatic cancers. Herein,
we identified a STAT3 inhibitor, inS3-54, by targeting the DNA-binding
domain of STAT3 using an improved virtual screening strategy. InS3-54
preferentially suppresses proliferation of cancer over non-cancer
cells and inhibits migration and invasion of malignant cells. Biochemical
analyses show that inS3-54 selectively inhibits STAT3 binding to DNA
without affecting the activation and dimerization of STAT3. Furthermore,
inS3-54 inhibits expression of STAT3 downstream target genes and STAT3
binding to chromatin in situ. Thus, inS3-54 represents a novel probe
for development of specific inhibitors targeting the DNA-binding domain
of STAT3 and a potential therapeutic for cancer treatments
14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle via PARP1 and CHK2
14-3-3σ has been implicated in the development of chemo and radiation resistance and in poor prognosis of multiple human cancers. While it has been postulated that 14-3-3σ contributes to these resistances via inhibiting apoptosis and arresting cells in G2–M phase of the cell cycle, the molecular basis of this regulation is currently unknown. In this study, we tested the hypothesis that 14-3-3σ causes resistance to DNA-damaging treatments by enhancing DNA repair in cells arrested in G2–M phase following DNA-damaging treatments. We showed that 14-3-3σ contributed to ionizing radiation (IR) resistance by arresting cancer cells in G2–M phase following IR and by increasing non-homologous end joining (NHEJ) repair of the IR-induced DNA double strand breaks (DSB). The increased NHEJ repair activity was due to 14-3-3σ–mediated upregulation of PARP1 expression that promoted the recruitment of DNA-PKcs to the DNA damage sites for repair of DSBs. On the other hand, the increased G2–M arrest following IR was due to 14-3-3σ–induced Chk2 expression.
Implications: These findings reveal an important molecular basis of 14-3-3σ function in cancer cell resistance to chemo/radiation therapy and in poor prognosis of human cancers
Dynamic Focus-aware Positional Queries for Semantic Segmentation
Most of the latest top semantic segmentation approaches are based on vision
Transformers, particularly DETR-like frameworks, which employ a set of queries
in the Transformer decoder. Each query is composed of a content query that
preserves semantic information and a positional query that provides positional
guidance for aggregating the query-specific context. However, the positional
queries in the Transformer decoder layers are typically represented as fixed
learnable weights, which often encode dataset statistics for segments and can
be inaccurate for individual samples. Therefore, in this paper, we propose to
generate positional queries dynamically conditioned on the cross-attention
scores and the localization information of the preceding layer. By doing so,
each query is aware of its previous focus, thus providing more accurate
positional guidance and encouraging the cross-attention consistency across the
decoder layers. In addition, we also propose an efficient way to deal with
high-resolution cross-attention by dynamically determining the contextual
tokens based on the low-resolution cross-attention maps to perform local
relation aggregation. Our overall framework termed FASeg (Focus-Aware semantic
Segmentation) provides a simple yet effective solution for semantic
segmentation. Extensive experiments on ADE20K and Cityscapes show that our
FASeg achieves state-of-the-art performance, e.g., obtaining 48.3% and 49.6%
mIoU respectively for single-scale inference on ADE20K validation set with
ResNet-50 and Swin-T backbones, and barely increases the computation
consumption from Mask2former. Source code will be made publicly available at
https://github.com/zip-group/FASeg.Comment: Tech repor
- …